Literature DB >> 11411436

Oocyte donation treats infertility in survivors of malignancies: ten-year experience.

S M Kavic1, M V Sauer.   

Abstract

Women who are survivors of malignancy may achieve pregnancy through oocyte donation. The largest obstacle to successful reproduction in cancer patients relates to iatrogenic damage to the primary reproductive organs associated with their primary oncology treatment. Reactive damage from surgery, radiation, or chemotherapy may render these organs nonfunctional and irreparable. In cases where the ovary is primarily affected, oocyte donation provides a logical alternative for childbearing.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11411436      PMCID： PMC3455592          DOI： 10.1023/a:1016605102539

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


  8 in total

1.  Cancer statistics, 1990.

Authors:  E Silverberg; C C Boring; T S Squires
Journal:  CA Cancer J Clin       Date:  1990 Jan-Feb       Impact factor: 508.702

2.  Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity.

Authors:  R J Paulson; I E Hatch; R A Lobo; M V Sauer
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

3.  Prospects for fertility after chemotherapy or radiation for neoplastic disease.

Authors:  M D Damewood; L B Grochow
Journal:  Fertil Steril       Date:  1986-04       Impact factor: 7.329

4.  A preliminary report on oocyte donation extending reproductive potential to women over 40.

Authors:  M V Sauer; R J Paulson; R A Lobo
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

Review 5.  New advances in the treatment of infertility in women with ovarian failure.

Authors:  R S Morris; M V Sauer
Journal:  Curr Opin Obstet Gynecol       Date:  1993-06       Impact factor: 1.927

6.  Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates.

Authors:  M V Sauer; R J Paulson; B A Ary; R A Lobo
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

7.  Pregnancy outcome of patients treated for Hodgkin's disease: a controlled study.

Authors:  G E Holmes; F F Holmes
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

8.  Female reproductive potential after treatment for Hodgkin's disease.

Authors:  S J Horning; R T Hoppe; H S Kaplan; S A Rosenberg
Journal:  N Engl J Med       Date:  1981-06-04       Impact factor: 91.245
  8 in total
  3 in total

1.  Development of hypertensive complications in oocyte donation pregnancy: protocol for a systematic review and individual participant data meta-analysis (DONOR IPD).

Authors:  Kim van Bentem; Marie-Louise van der Hoorn; Jan van Lith; Saskia le Cessie; Eileen Lashley
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

2.  Comparison of Obstetric Outcomes of Pregnancies after Donor-Oocyte In vitro Fertilization and Self-Oocyte In vitro Fertilization: A Retrospective Cohort Study.

Authors:  Vikas Yadav; Priyanka Bakolia; Neena Malhotra; Reeta Mahey; Neeta Singh; Alka Kriplani
Journal:  J Hum Reprod Sci       Date:  2018 Oct-Dec

3.  Comparison of Obstetric Outcomes Between IVF cycles with Donor Oocyte and Spontaneous Conception Pregnancies: A Retrospective Cohort study.

Authors:  Yadav Vikas; Malhotra Neena; Mahey Reeta; Singh Neeta; Kriplani Alka
Journal:  J Reprod Infertil       Date:  2022 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.